180 related articles for article (PubMed ID: 28728591)
1. Antimicrobial susceptibility pattern of clinical isolates of Burkholderia pseudomallei in Bangladesh.
Dutta S; Haq S; Hasan MR; Haq JA
BMC Res Notes; 2017 Jul; 10(1):299. PubMed ID: 28728591
[TBL] [Abstract][Full Text] [Related]
2. Antimicrobial susceptibility of Burkholderia pseudomallei isolates in Northern Vietnam.
Nhung PH; Van VH; Anh NQ; Phuong DM
J Glob Antimicrob Resist; 2019 Sep; 18():34-36. PubMed ID: 30685463
[TBL] [Abstract][Full Text] [Related]
3. Current antimicrobial susceptibility of first-episode melioidosis Burkholderia pseudomallei isolates from the Northern Territory, Australia.
Crowe A; McMahon N; Currie BJ; Baird RW
Int J Antimicrob Agents; 2014 Aug; 44(2):160-2. PubMed ID: 24924662
[TBL] [Abstract][Full Text] [Related]
4. Epidemiological cut-off value of clinical isolates of Burkholderia pseudomallei from Northern Queensland to meropenem, ceftazidime, trimethoprim/sulfamethoxazole and doxycycline by the microbroth dilution method.
Maloney S; Engler C; Norton R
J Glob Antimicrob Resist; 2017 Sep; 10():291-294. PubMed ID: 28729203
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial susceptibility patterns of Burkholderia pseudomallei among melioidosis cases in Kedah, Malaysia.
Hassan MR; Vijayalakshmi N; Pani SP; Peng NP; Mehenderkar R; Voralu K; Michael E
Southeast Asian J Trop Med Public Health; 2014 May; 45(3):680-8. PubMed ID: 24974653
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of bla(PenA) and bla(OXA) in Burkholderia pseudomallei Isolated from Patients at Sappasitthiprasong Hospital and Their Susceptibility to Ceftazidime and Carbapenems.
Panya M; Thirat S; Wanram S; Panomket P; Nilsakul J
J Med Assoc Thai; 2016 Jan; 99 Suppl 1():S12-6. PubMed ID: 26817233
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial susceptibility and genetic characterisation of Burkholderia pseudomallei isolated from Malaysian patients.
Khosravi Y; Vellasamy KM; Mariappan V; Ng SL; Vadivelu J
ScientificWorldJournal; 2014; 2014():132971. PubMed ID: 25379514
[TBL] [Abstract][Full Text] [Related]
8. Comparison between the antimicrobial susceptibility of Burkholderia pseudomallei to trimethoprim-sulfamethoxazole by standard disk diffusion method and by minimal inhibitory concentration determination.
Lumbiganon P; Tattawasatra U; Chetchotisakd P; Wongratanacheewin S; Thinkhamrop B
J Med Assoc Thai; 2000 Aug; 83(8):856-60. PubMed ID: 10998837
[TBL] [Abstract][Full Text] [Related]
9. Burkholderia pseudomallei: in vitro susceptibility to some new and old antimicrobials.
Karunakaran R; Puthucheary SD
Scand J Infect Dis; 2007; 39(10):858-61. PubMed ID: 17852912
[TBL] [Abstract][Full Text] [Related]
10. The antibiotics of choice for the treatment of melioidosis in Indian set up.
Shaw T; Tellapragada C; Eshwara VK; Bhat HV; Mukhopadhyay C
Indian J Med Microbiol; 2016; 34(3):353-4. PubMed ID: 27514960
[TBL] [Abstract][Full Text] [Related]
11. Cases of melioidosis in a university teaching hospital in Malaysia.
Raja NS
J Microbiol Immunol Infect; 2008 Apr; 41(2):174-9. PubMed ID: 18473106
[TBL] [Abstract][Full Text] [Related]
12. Activity of Ceftolozane-Tazobactam against
Slack A; Parsonson F; Cronin K; Engler C; Norton R
Am J Trop Med Hyg; 2018 Aug; 99(2):281-282. PubMed ID: 29943711
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial Susceptibility of Western Hemisphere Isolates of
Bugrysheva JV; Lascols C; McLaughlin HP; Gee JE; Elrod MG; Sue D
Microb Drug Resist; 2021 Sep; 27(9):1176-1185. PubMed ID: 33570476
[TBL] [Abstract][Full Text] [Related]
14. Antibiotic susceptibility of 65 isolates of Burkholderia pseudomallei and Burkholderia mallei to 35 antimicrobial agents.
Thibault FM; Hernandez E; Vidal DR; Girardet M; Cavallo JD
J Antimicrob Chemother; 2004 Dec; 54(6):1134-8. PubMed ID: 15509614
[TBL] [Abstract][Full Text] [Related]
15. Identification and Characterization of Burkholderia pseudomallei from Localized Pyogenic Infections in Eastern India: A Clinico-Microbiological Study.
Purushotham P; Mohanty S; Chappity P; Mishra TS; Mahapatra A
Am J Trop Med Hyg; 2021 Feb; 104(4):1252-1259. PubMed ID: 33534740
[TBL] [Abstract][Full Text] [Related]
16. Burkholderia pseudomallei: Its Detection in Soil and Seroprevalence in Bangladesh.
Jilani MS; Robayet JA; Mohiuddin M; Hasan MR; Ahsan CR; Haq JA
PLoS Negl Trop Dis; 2016 Jan; 10(1):e0004301. PubMed ID: 26771511
[TBL] [Abstract][Full Text] [Related]
17. Farnesol increases the susceptibility of Burkholderia pseudomallei biofilm to antimicrobials used to treat melioidosis.
Castelo-Branco DS; Riello GB; Vasconcelos DC; Guedes GM; Serpa R; Bandeira TJ; Monteiro AJ; Cordeiro RA; Rocha MF; Sidrim JJ; Brilhante RS
J Appl Microbiol; 2016 Mar; 120(3):600-6. PubMed ID: 26669506
[TBL] [Abstract][Full Text] [Related]
18. Correlation Between Etest and Reference Broth Microdilution for Antimicrobial Susceptibility Testing of
Lonsway DR; Elrod MG; Kendrick N; Tiller R; Sullivan MM; Edwards JR; Blaney DD; Karlsson M
Microb Drug Resist; 2020 Apr; 26(4):311-318. PubMed ID: 31596673
[TBL] [Abstract][Full Text] [Related]
19. Comparative in vitro susceptibility of Burkholderia pseudomallei to doripenem, ertapenem, tigecycline and moxifloxacin.
Harris P; Engler C; Norton R
Int J Antimicrob Agents; 2011 Jun; 37(6):547-9. PubMed ID: 21481571
[TBL] [Abstract][Full Text] [Related]
20. Raising the Stakes: Loss of Efflux Pump Regulation Decreases Meropenem Susceptibility in Burkholderia pseudomallei.
Sarovich DS; Webb JR; Pitman MC; Viberg LT; Mayo M; Baird RW; Robson JM; Currie BJ; Price EP
Clin Infect Dis; 2018 Jul; 67(2):243-250. PubMed ID: 29394337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]